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A B S T R A C T
Streptococcus pneumoniae is an important human pathogen. To cause disease, it must ﬁrst colonize the
nasopharynx. The widespread use of pneumococcal-conjugate vaccines which target the capsular
polysaccharide has led to decreased nasopharyngeal carriage of vaccine serotypes, but a concomitant
increase in carriage of non-vaccine serotypes and nonencapsulated S. pneumoniae (NESp). Some NESp
express pneumococcal surface protein K (PspK), a virulence factor shown to contribute to
nasopharyngeal colonization.
We present the case of a child with chronic adenoiditis caused by a PspK+ NESp. We tested the
pneumococcal isolate, designated C144.66, for antimicrobial resistance, the presence of the pspK gene
and the expression of PspK. Sequence typing and genome sequencing were performed. C144.66 was
found to be resistant to erythromycin and displayed intermediate resistance to penicillin and
trimethoprim/sulfamethoxazole. C144.66 has the pspK gene in place of the capsule locus. Additionally,
PspK expression was conﬁrmed by ﬂow cytometry. NESp are a growing concern as an emerging human
pathogen, as current pneumococcal vaccines do not confer immunity against them. An inability to
vaccinate against NESp may result in increased carriage and associated pathology.
 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Streptococcus pneumoniae is the most common bacterial cause
of acute otitis media (AOM) and pneumonia in children [1,2]. The
pneumococcus is an important cause of bacterial rhinosinusitis as
well as invasive disease such as sepsis and meningitis [3].
Historically, pneumococci that cause disease are encapsulated.
Therefore, the 13-valent pneumococcal conjugate polysaccharide
vaccine (PCV) and the 23-valent pneumococcal polysaccharide
vaccine (PPV) target the speciﬁc capsular serotypes known to cause
the majority of human disease [4]. Introduction of the PCV and PPV
has led to decreased nasopharyngeal colonization of pneumococcal
vaccine serotypes in humans, with a concomitant increase in
isolation of both non-vaccine capsular serotypes and nonencapsu-
lated S. pneumoniae (NESp) [5,6]. There has, additionally, been an
increase in prevalence of disease caused by NESp [7–15].* Corresponding author at: University of Mississippi Medical Center, 2500 North
State Street, Jackson, MS 39216, United States. Tel.: +1 601 984 6880;
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4.0/).Some NESp isolates express pneumococcal surface protein K
(PspK) [12]. PspK has been shown to aid colonization of the
nasopharynx [16]. We have previously shown that PspK increases
adhesion of NESp to human epithelial cells and enhances AOM in
the chinchilla model [17]. Expression of PspK in an avirulent NESp
was sufﬁcient to induce pathogenicity, and deletion of PspK from a
virulent strain decreased the bacterial burden in chinchillas [17].
We present a case of a child with chronic adenoiditis found to have
PspK+ NESp from a sinus culture at adenoidectomy. To our
knowledge, this is the ﬁrst report of a PspK+ NESp isolate from the
United States.
Case report
A 2-year-old male presented to otolaryngology clinic for
evaluation of chronic adenoiditis. Patient had a 6 month history
of nasal congestion with a clear mucosal discharge and was a
chronic mouth breather since birth. Of note, patient was refractory
to several trials of antimicrobials. Enlarged adenoids were
appreciated on physical exam. The patient’s family was counseled
and elected to undergo adenoidectomy, which was completed
without complication. During the procedure, bilateral maxillarye under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
Table 1
Antimicrobial susceptibility of S. pneumoniae C144.66.
Antibiotic Resistance
Erythromycin Resistant
Penicillin G Intermediate
Trimethoprim/sulfamethoxazole Intermediate
Levoﬂoxacin Susceptible
Tetracycline Susceptible
Vancomycin Susceptible
Cefotaxime Susceptible
Ceftriaxone Susceptible
Chloramphenicol Susceptible
Fig. 2. Flow cytometry for the presence of PspK. For analysis 1  107 log phase
pneumococci were incubated with a mouse anti-PspK antiserum. A biotinylated
anti-mouse secondary antibody was detected by streptavidin conjugated to Alex
Flour 488. A representative histogram is shown. The negative control is MNZ85
which lacks PspK.
C. Dixit et al. / IDCases 4 (2016) 56–58 57sinuses were aspirated, both revealing sanguineous ﬂuid that was
sent for aerobic and anaerobic culture. The sinuses were then
irrigated with saline. The right sinus culture returned with no
growth after 48 h, and the left sinus culture had moderate growth
of S. pneumoniae. Anaerobic cultures showed no growth. After 24 h
observation, the patient was discharged. After discharge, the
patient was lost to follow up.
Antimicrobial sensitivities of the isolate, complete with
minimum inhibitory concentrations, showed erythromycin resis-
tance, as well as intermediate resistance to both penicillin G and
trimethoprim/sulfamethoxazole (Table 1).
The clinical isolate was designated C144.66. Genomic DNA was
isolated from C144.66 using Qiagen DNeasy kit. Polymerase chain
reaction ampliﬁcation was performed with primers for pspK,
LSM826 (50-CCCGGGGCATGAATAATAAGAATATCA-30) and LSM827
(50-GAATTCGCCTAATTTTTATGTTTAACAAATG-30) and for the con-
served capsule gene cpsA (forward: 50-GCAGTACAGCAGTTTGTTG-
GACTGACC-30 and reverse: 50-GAATATTTTCATTATCAGTCCCAGTC-
30). PCR, Western blot analysis, and ﬂow cytometry were
completed through standard methods [16,18]. Polymerase chain
reaction analysis compared to an encapsulated strain showed that
C144.66 lacked the highly conserved ﬁrst gene in the capsule locus,
cpsA (Fig. 1). Further PCR analysis demonstrated the presence of
pspK. Expression of PspK was conﬁrmed through Western blot
(data not shown), and ﬂow cytometry comparing C144.66 to a
known PspK positive strain (Fig. 2).
To further characterize C144.66, multilocus sequence typing
was performed as previously described [19]. Additionally, genome
sequencing was carried out on C144.66. Multiplexed paired-end
libraries (2 150 bp) were prepared using a Nextera XT DNA
sample preparation kit (Illumina). Sequencing was done with an
Illumina MiSeq. CLC Genomics Workbench v6.0 software was used
for quality trimming of the reads and de novo assembly.
Rapid Annotations using Subsystems Technology (RAST) pipelineFig. 1. PCR analysis of C144.66. PCR analysis of strains MNZ11 (cpsA, pspK+) D39
(cpsA+, pspK), and C144.66 (cpsA, pspK+), respectively, for cpsA (lanes 2–4) and
pspK (lanes 5–7). Lane 1 is a 1-Kb DNA ladder.determined gene prediction and annotation for the assembled
contigs.
The sequence type (ST) of C144.66 was 9570. A draft genome
sequence of C144.66 was generated to provide further information
about the strain. Both approaches conﬁrmed that C144.66 was a
PspK+ NESp.
We previously demonstrated that C144.66 can cause AOM in
the chinchilla model [17]. To extend our observation, we used a
mouse model of colonization. C57/BL6 mice were anesthetized
with isoﬂurane and infected by inoculation with 1  107 colony
forming units of C144.66 into the nasal passage. After 5 days, the
mice were euthanized. Nasopharyngeal washes as well as nasalFig. 3. Colonization and ascension of C144.66 in a murine model. After intranasal
inoculation of C144.66, colonization was achieved in all mice. Ascension into the
middle ear occurred in two of the ﬁve mice. The dash line is the lower limit of
detection.
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load by plating on blood agar with 200 mg/mL gentamicin. All mice
were found to have nasopharyngeal colonization by C144.66;
additionally, C144.66 was found to have ascended to the middle
ear in a subset of the mice (Fig. 3).
Conclusion
This case of chronic adenoiditis caused by NESp reinforces the
growing concern of infection caused by pneumococcal strains not
covered by the current vaccines. With widespread use of PCV and
PPV, human nasopharyngeal colonization by NESp will likely
continue to increase.
Since pneumococcal colonization is a prerequisite for disease, it
is likely that with increased carriage of NESp there will be
increased disease burden. A recent study from Japan found that
6.4% of AOM isolates were NESp with 4.7% of the NESp being PspK
positive [20]. AOM is the most common indication for antimicro-
bial prescription for children in the United States, and has a
ﬁnancial burden in excess of $2.8 billion, a number likely to grow
with increasing infections with non-vaccine serotypes and NESp
[21]. After widespread use of the 7-valent PCV (prior to the
introduction of the 13-valent PCV), new serotypes, including
capsular serotype 19A, emerged; some strains were multidrug
resistant [22,23]. Studies have shown that NESp can contain
multiple antimicrobial resistance genes [24–26]. Thus, co-coloni-
zation of NESp with encapsulated pneumococci could lead to
increased antimicrobial resistance among encapsulated pneumo-
cocci. Additionally, there is concern for the emergence of novel
serotypes as well as proliferation of NESp with novel proteins, such
as PspK, which are not covered by currently available pneumo-
coccal vaccines.
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